tiprankstipranks
Trending News
More News >
Butterfly Network, Inc. (BFLY)
:BFLY
US Market
Advertisement

Butterfly Network (BFLY) AI Stock Analysis

Compare
1,768 Followers

Top Page

BFLY

Butterfly Network

(NYSE:BFLY)

Rating:44Neutral
Price Target:
$1.50
▲(4.90% Upside)
Butterfly Network faces substantial financial and technical challenges, with significant operational inefficiencies impacting profitability and cash flow. Despite record revenue and strategic initiatives, the stock remains under pressure from bearish technical indicators and a weak valuation. Positive aspects include strong gross margins and low leverage, with optimism for future growth following recent corporate events.
Positive Factors
Growth Opportunities
BFLY has several big growth drivers, including the worldwide rollout of iQ3, the upcoming launch of Compass 2.0 software, and a major Octiv partnership.
Product Innovation
BFLY’s AI-driven tools for aortic stenosis and AAA screening mark a major step in expanding the clinical utility of its Butterfly iQ handheld ultrasound platform.
Revenue Growth
Total revenue increased 20% with a notable rise in US revenue driven by higher sales volume to health systems and the delivery of semiconductor chips to new partners.
Negative Factors
Management Changes
Butterfly announced that CFO Heather Getz resigned to pursue other interests.
Revenue Guidance
Butterfly reported a mixed second-quarter update with revenue slightly missing expectations, full-year revenue guidance lowered by $5 million (~5%).
Sales Challenges
The evolving macro environment has elongated the US hospital sales cycle and pushed out some large enterprise deals.

Butterfly Network (BFLY) vs. SPDR S&P 500 ETF (SPY)

Butterfly Network Business Overview & Revenue Model

Company DescriptionButterfly Network, Inc. (BFLY) is a digital health company that is revolutionizing medical imaging. It operates in the healthcare technology sector, focusing on the development of its handheld, pocket-sized ultrasound device known as the Butterfly iQ+. This device leverages a semiconductor chip to create high-quality medical imaging, making ultrasound technology more accessible and affordable for healthcare professionals worldwide. The company's mission is to democratize medical imaging and make it universally available.
How the Company Makes MoneyButterfly Network generates revenue primarily through the sale of its ultrasound devices. The Butterfly iQ+ is sold directly to healthcare providers, hospitals, and other medical institutions. Additionally, the company offers a subscription-based model for its software platform, which provides users with cloud storage, advanced imaging tools, and telemedicine capabilities. This software subscription model ensures a steady stream of recurring revenue. Butterfly Network also engages in partnerships with healthcare organizations and educational institutions to expand its market reach and bolster sales. These collaborations can include joint research initiatives, co-development projects, and distribution agreements that further contribute to its financial growth.

Butterfly Network Earnings Call Summary

Earnings Call Date:Aug 01, 2025
(Q2-2025)
|
% Change Since: -16.37%|
Next Earnings Date:Oct 30, 2025
Earnings Call Sentiment Neutral
The earnings call presented a strong performance with record-breaking revenue and successful strategic initiatives. However, the impact of macroeconomic uncertainties led to delayed deal closures and a reduction in full-year revenue guidance. Despite these challenges, the company remains optimistic about its future growth potential.
Q2-2025 Updates
Positive Updates
Record-Breaking Revenue and Growth
The company delivered its highest quarterly revenue in history, totaling $23.4 million, marking a 9% growth from the previous year. Gross margins also reached an all-time high at 64%.
Successful Large Enterprise Deal
Closed a large enterprise-wide deal with one of the top 5 most recognized health systems globally. Full deployment in every department and campus is underway.
Butterfly Garden Progress
Added two new Butterfly Garden partners, with FDA clearance received for three applications. HeartFocus is expected to launch in the third quarter, marking the entry into the commercial phase.
Positive Impact of Octiv
Octiv continues to positively impact top and bottom lines, with partnerships leading to increased technology awareness and potential new revenue streams.
Compass AI Launch
Announcement of a new software platform, Compass AI, aimed at reducing documentation steps and increasing penetration within existing customers.
Significant Improvement in Adjusted EBITDA
Adjusted EBITDA loss improved by 24% compared to the previous year, driven by higher revenue and improved gross profit.
Negative Updates
Delayed Large Deal Closures
Customers delayed purchase decisions due to uncertainties regarding changes in funding and government programs, impacting U.S. hospital and enterprise channels.
Reduced Full-Year Revenue Guidance
Full-year revenue guidance was adjusted to a range of $91 million to $95 million due to the delayed closing of larger deals and uncertain macro conditions.
Flat U.S. Revenue
U.S. revenue was flat compared to the previous year, despite higher average selling prices, due to lower probe volume and fewer trade-ins/upgrades.
Churn in Individual Software Subscriptions
High churn rate in individual software subscriptions, with difficulties in renewing them after the initial term.
Company Guidance
During the second quarter of 2025, Butterfly Network achieved its highest quarterly revenue in company history, totaling $23.4 million, marking a 9% growth year-over-year. The company saw its gross margins reach an all-time high of 64%, while cash use was the lowest of any quarter at $7 million. Despite some macroeconomic headwinds, the guidance provided for Q2 was met, with expectations that these conditions will persist through the end of the year. The company adjusted its full-year revenue guidance to a range of $91 million to $95 million, reflecting both uncertainties in health care funding and delayed purchases by customers. Adjusted EBITDA loss guidance was revised positively to a range of $32 million to $37 million, highlighting fiscal discipline. Butterfly Network continues to focus on growing its core business and leveraging strategic initiatives such as Octiv and HomeCare, with the launch of Compass AI expected to enhance enterprise software capabilities significantly.

Butterfly Network Financial Statement Overview

Summary
Butterfly Network has shown some revenue growth and strong cost management with a positive gross profit margin of 60.65%. However, the company faces significant financial challenges, including negative net profit and EBIT margins, and ongoing cash flow difficulties. The balance sheet shows low leverage, but persistent losses and cash outflows pose risks to financial stability.
Income Statement
40
Negative
Butterfly Network has shown modest revenue growth with a year-over-year increase of approximately 4.35% in the TTM. However, the company is currently unprofitable with a negative net profit margin of -75.57% and a negative EBIT margin of -81.35%, indicating significant operational challenges. The gross profit margin is positive at 60.65%, suggesting some strength in cost management, but overall profitability remains a concern.
Balance Sheet
50
Neutral
The company's balance sheet reflects a moderate level of stability with a debt-to-equity ratio of 0.08, indicating low leverage. The equity ratio is relatively strong at 75.27%, demonstrating a solid equity base relative to total assets. However, the company has been consistently recording negative net income, which adversely affects return on equity, currently not calculable due to negative net income.
Cash Flow
45
Neutral
Butterfly Network's cash flow situation is challenging, with negative free cash flow and operating cash flow in the TTM. Despite a reduction in negative free cash flow compared to the previous period, the company continues to experience cash outflows from operations, affecting its liquidity position. The operating cash flow to net income ratio is not favorable, reflecting the need for better cash management strategies.
BreakdownTTMDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Income Statement
Total Revenue87.52M82.06M65.90M73.39M62.56M46.25M
Gross Profit54.24M48.83M16.86M39.46M17.05M-61.22M
EBITDA-57.79M-60.92M-124.84M-162.74M-29.55M-160.25M
Net Income-62.83M-72.49M-133.70M-168.72M-32.41M-162.75M
Balance Sheet
Total Assets313.28M256.08M304.27M417.57M571.97M147.19M
Cash, Cash Equivalents and Short-Term Investments148.14M88.78M134.44M237.81M422.84M60.21M
Total Debt19.10M22.84M25.03M31.89M27.69M53.89M
Total Liabilities80.47M87.25M84.22M92.21M124.27M509.12M
Stockholders Equity232.81M168.83M220.05M325.36M447.69M-361.93M
Cash Flow
Free Cash Flow-31.95M-44.40M-104.60M-187.42M-197.06M-84.08M
Operating Cash Flow-29.88M-41.71M-98.82M-169.12M-189.19M-81.70M
Investing Cash Flow-2.07M-2.66M70.41M-93.78M-9.87M-2.38M
Financing Cash Flow77.96M-1.50M228.00K2.88M565.69M54.28M

Butterfly Network Technical Analysis

Technical Analysis Sentiment
Negative
Last Price1.43
Price Trends
50DMA
1.90
Negative
100DMA
2.12
Negative
200DMA
2.73
Negative
Market Momentum
MACD
-0.16
Positive
RSI
35.23
Neutral
STOCH
54.73
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For BFLY, the sentiment is Negative. The current price of 1.43 is below the 20-day moving average (MA) of 1.63, below the 50-day MA of 1.90, and below the 200-day MA of 2.73, indicating a bearish trend. The MACD of -0.16 indicates Positive momentum. The RSI at 35.23 is Neutral, neither overbought nor oversold. The STOCH value of 54.73 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for BFLY.

Butterfly Network Risk Analysis

Butterfly Network disclosed 48 risk factors in its most recent earnings report. Butterfly Network reported the most risks in the "Tech & Innovation" category.
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy
Latest Risks Added 0 New Risks

Butterfly Network Peers Comparison

Overall Rating
UnderperformOutperform
Sector (51)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
61
Neutral
$666.96M-14.18%22.93%43.83%
57
Neutral
$609.34M-0.10%5.08%99.38%
55
Neutral
$562.00M-24.63%4.84%0.85%
51
Neutral
$7.70B-0.29-46.01%2.24%23.07%-0.65%
50
Neutral
$481.16M-11.49%26.08%-63.67%
49
Neutral
$519.71M45.80-46.17%1.48%-6091.13%
44
Neutral
$359.99M-29.42%23.13%46.62%
* Healthcare Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
BFLY
Butterfly Network
1.43
0.45
45.92%
OFIX
Orthofix
14.23
-2.20
-13.39%
AVNS
Avanos Medical
11.20
-12.38
-52.50%
KIDS
OrthoPediatrics
19.19
-9.40
-32.88%
SIBN
SI-Bone
15.46
1.14
7.96%
BVS
Bioventus
7.37
-0.63
-7.87%

Butterfly Network Corporate Events

Executive/Board ChangesBusiness Operations and StrategyFinancial Disclosures
Butterfly Network CFO Transition and Financial Milestone
Positive
Aug 1, 2025

On August 1, 2025, Heather C. Getz stepped down as Butterfly Network‘s Executive Vice President and Chief Financial & Operations Officer, transitioning to an advisory role until March 2026. Megan Carlson, the Chief Accounting Officer, has been appointed as Interim Chief Financial Officer. The company has begun the search for a permanent CFO. This leadership transition is not due to any disagreements with the company. In the second quarter of 2025, Butterfly Network reported its highest quarterly revenue of $23.4 million and gross margins of 64%, marking a significant achievement in its financial performance. The company is focused on scaling its core business and exploring new revenue streams, with upcoming launches of advanced AI software and technology innovations, positioning itself as a leader in handheld ultrasound technology.

The most recent analyst rating on (BFLY) stock is a Buy with a $3.75 price target. To see the full list of analyst forecasts on Butterfly Network stock, see the BFLY Stock Forecast page.

Executive/Board ChangesShareholder Meetings
Butterfly Network Holds Annual Stockholders Meeting
Neutral
Jun 17, 2025

On June 12, 2025, Butterfly Network, Inc. held its Annual Meeting of Stockholders, where key decisions were made regarding the company’s governance and operations. The stockholders elected several directors for a one-year term, ratified the appointment of Deloitte & Touche LLP as the independent accounting firm, and approved the executive compensation package. These decisions reflect the company’s ongoing efforts to strengthen its leadership and financial oversight, potentially impacting its strategic direction and stakeholder confidence.

The most recent analyst rating on (BFLY) stock is a Buy with a $3.75 price target. To see the full list of analyst forecasts on Butterfly Network stock, see the BFLY Stock Forecast page.

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Aug 02, 2025